Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


13.02.2017

5 Am J Gastroenterol
2 Arch Virol
4 Clin Infect Dis
1 Dig Dis Sci
2 Gastroenterology
2 Gut
3 Hepatology
1 J Clin Gastroenterol
4 J Hepatol
2 J Med Virol
4 J Viral Hepat
1 J Virol
1 JAMA
2 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. KARIMI-SARI H, Tajik M, Bayatpoor ME, Alavian SM, et al
    Increasing the Awareness of the General Population: An Important Step in Elimination Programs of Viral Hepatitis.
    Am J Gastroenterol. 2017;112:393-395.
    PubMed     Text format    

  2. HUANG YW, Hsieh AC, Yang SS
    Safety of Statins in Chronic Hepatitis B Patients.
    Am J Gastroenterol. 2017;112:385-386.
    PubMed     Text format    

  3. TAKYAR V, Kleiner DE, Koh C
    A Wolf in Sheep's Clothing in the Era of Non-Invasive Staging: Non-Hodgkin's Lymphoma Masquerading as Serologic HCV Cirrhosis.
    Am J Gastroenterol. 2017;112:398-399.
    PubMed     Text format    

  4. LO GH
    Did Statins Really Reduce the Risk of Cirrhosis and Decompensation in Chronic Hepatitis B Patients?
    Am J Gastroenterol. 2017;112:386-387.
    PubMed     Text format    

  5. YANG JD, Mohamed HA, Cvinar JL, Gores GJ, et al
    Corrigendum: Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Am J Gastroenterol. 2017;112:402.
    PubMed     Text format    


    Arch Virol

  6. SPITZ N, Moreira AS, Mello FC, Franz HC, et al
    Complete genome sequence of a hepatitis B virus isolate of genotype D2, subtype adrq+, from Brazil.
    Arch Virol. 2017 Feb 8. doi: 10.1007/s00705-017-3269.
    PubMed     Text format     Abstract available

  7. NICZYPORUK JS
    Molecular characterisation of fowl adenovirus type 7 isolated from poultry associated with inclusion body hepatitis in Poland.
    Arch Virol. 2017 Feb 3. doi: 10.1007/s00705-017-3240.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  8. KOVARI H, Rauch A, Kouyos R, Rougemont M, et al
    Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017;64:490-497.
    PubMed     Text format    

  9. LO RE V
    Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.
    Clin Infect Dis. 2017;64:498-500.
    PubMed     Text format    

  10. VEENHUIS RT, Astemborski J, Chattergoon MA, Greenwood P, et al
    Systemic Elevation of Proinflammatory Interleukin-18 in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Coinfection Versus HIV or HCV Monoinfection.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    

  11. ANDREONI M, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients With HIV/HCV Coinfection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


    Dig Dis Sci

  12. AHN J, Liu B, Bhuket T, Wong RJ, et al
    Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Dig Dis Sci. 2017 Feb 6. doi: 10.1007/s10620-017-4469.
    PubMed     Text format     Abstract available


    Gastroenterology

  13. MATSUURA K, Sawai H, Ikeo K, Ogawa S, et al
    Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Gastroenterology. 2017 Feb 2. pii: S0016-5085(17)30130.
    PubMed     Text format     Abstract available

  14. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    


    Gut

  15. VAN RENNE N, Roca Suarez AA, Duong FH, Gondeau C, et al
    miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis.
    Gut. 2017 Feb 3. pii: gutjnl-2016-312270. doi: 10.1136/gutjnl-2016-312270.
    PubMed     Text format     Abstract available


  16. Erratum: Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort.
    Gut. 2016;65:2060.
    PubMed     Text format    


    Hepatology

  17. CARTER L, Aronsohn A
    Overcoming Injustice: A Roadmap to Improve Access to HCV Therapy for Our Medicaid Patients.
    Hepatology. 2017 Feb 4. doi: 10.1002/hep.29095.
    PubMed     Text format    

  18. FERNANDEZ CARRILLO C, Lens S, Llop E, Pascasio JM, et al
    Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of MELD: Analysis of data from the Hepa-C registry.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29097.
    PubMed     Text format     Abstract available

  19. DENOLLY S, Cosset FL
    A master regulator of tight junctions involved in hepatitis C virus entry and pathogenesis.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.29066.
    PubMed     Text format    


    J Clin Gastroenterol

  20. DAILEY F, Ayoub WS
    Hepatitis C Virus Therapy for Decompensated and Posttransplant Patients.
    J Clin Gastroenterol. 2017;51:215-222.
    PubMed     Text format     Abstract available


    J Hepatol

  21. GREBELY J, Swan T, Hickman M, Bruneau J, et al
    Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C.
    J Hepatol. 2017 Feb 3. pii: S0168-8278(17)30054.
    PubMed     Text format    

  22. PAWLOTSKY JM
    Consistent advice for people who inject drugs in the 2016 EASL Recommendations on treatment of hepatitis C.
    J Hepatol. 2017 Feb 3. pii: S0168-8278(17)30055.
    PubMed     Text format    

  23. ATKINSON SR, Way MJ, McQuillin A, Morgan MY, et al
    Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.
    J Hepatol. 2017 Feb 1. pii: S0168-8278(17)30051.
    PubMed     Text format     Abstract available

  24. PRENNER S, VanWagner LB, Flamm SL, Salem R, et al
    Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy with Direct-Acting Antivirals.
    J Hepatol. 2017 Feb 1. pii: S0168-8278(17)30053.
    PubMed     Text format     Abstract available


    J Med Virol

  25. WATANABE T, Tokumoto Y, Joko K, Michitaka K, et al
    Predictors of treatment efficacy and ALT non-normalization with sofosbuvir/ribavirin therapy for patients with hepatitis C virus genotype 2.
    J Med Virol. 2017 Feb 6. doi: 10.1002/jmv.24776.
    PubMed     Text format     Abstract available

  26. FLORES GL, Cruz HM, Marques VA, Villela-Nogueira CA, et al
    Performance of anti-HCV testing in dried blood spots and saliva according to HIV status.
    J Med Virol. 2017 Feb 6. doi: 10.1002/jmv.24777.
    PubMed     Text format     Abstract available


    J Viral Hepat

  27. INGILIZ P
    Martinello et al.,HCV reinfection incidence among individuals treated for recent infection.
    J Viral Hepat. 2017 Feb 7. doi: 10.1111/jvh.12686.
    PubMed     Text format     Abstract available

  28. SOOMRO MH, Shi R, She R, Yang Y, et al
    Molecular and structural changes related to Hepatitis E virus (HEV) antigen and its expression in testis inducing apoptosis in Mongolian gerbil model.
    J Viral Hepat. 2017 Feb 9. doi: 10.1111/jvh.12690.
    PubMed     Text format     Abstract available

  29. HSU HY, Chang MH, Ni YH, Chiang CL, et al
    Chronologic changes of serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan.
    J Viral Hepat. 2017 Feb 9. doi: 10.1111/jvh.12687.
    PubMed     Text format     Abstract available

  30. MEIER MA, Suslov A, Ketterer S, Heim MH, et al
    Hepatitis B Virus covalently closed circular DNA homeostasis is independent of the lymphotoxin pathway during chronic HBV infection.
    J Viral Hepat. 2017 Feb 9. doi: 10.1111/jvh.12689.
    PubMed     Text format     Abstract available


    J Virol

  31. HADDAD J, Rouille Y, Hanoulle X, Descamps V, et al
    Identification of novel functions for hepatitis C virus envelope glycoprotein E1 in virus entry and assembly.
    J Virol. 2017 Feb 8. pii: JVI.00048-17. doi: 10.1128/JVI.00048.
    PubMed     Text format     Abstract available


    JAMA

  32. LYON J
    Study Suggests Alzheimer and Parkinson Disease Are Not Transmitted Through Blood Transfusion.
    JAMA. 2016 Dec 21. doi: 10.1001/jama.2016.16260.
    PubMed     Text format    


    PLoS One

  33. WU B, Xiao F, Li P, Du Y, et al
    Ultrasensitive detection of serum hepatitis B virus by coupling ultrafiltration DNA extraction with real-time PCR.
    PLoS One. 2017;12:e0170290.
    PubMed     Text format     Abstract available

  34. ZHANG C, Hua R, Cui Y, Wang S, et al
    Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance.
    PLoS One. 2017;12:e0171217.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  35. KOIZUMI Y, Ohashi H, Nakajima S, Tanaka Y, et al
    Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 7. pii: 201610197.
    PubMed     Text format     Abstract available

  36. QI H, Chu V, Wu NC, Chen Z, et al
    Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
    Proc Natl Acad Sci U S A. 2017 Feb 3. pii: 201614623.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: